Table 1 Characteristics of non-Cochrane child-relevant systematic reviews published in 2014, overall and by type of review question
From: A descriptive analysis of non-Cochrane child-relevant systematic reviews published in 2014
Review characteristics | Overall | Type of review questiona | |||
|---|---|---|---|---|---|
Therapeutic | Epidemiology | Diagnostic/Prognostic | Other | ||
Total number of systematic reviews (%) | 1598 (100.0) | 753 (47.1) | 701 (43.8) | 91 (5.7) | 53 (3.3) |
Corresponding author: continent, n (%) | |||||
 Asia | 299 (18.7) | 123 (16.3) | 148 (21.1) | 25 (27.5) | 3 (5.7) |
 Africa | 24 (1.5) | 11 (1.5) | 11 (1.6) | 1 (1.1) | 1 (1.9) |
 North America | 534 (33.4) | 287 (38.1) | 199 (28.4) | 30 (33.0) | 18 (34.0) |
 South America | 65 (4.1) | 25 (3.3) | 37 (5.3) | 2 (2.2) | 1 (1.9) |
 Europe | 535 (33.5) | 255 (33.9) | 232 (33.1) | 26 (28.6) | 22 (41.5) |
 Oceania | 141 (8.8) | 52 (6.9) | 74 (10.6) | 7 (7.7) | 8 (15.1) |
Corresponding author: country income level (World Bank), n (%) | |||||
 High | 1247 (78.0) | 610 (81.0) | 524 (74.8) | 64 (70.3) | 49 (92.5) |
 Upper middle | 317 (19.8) | 126 (16.7) | 163 (23.3) | 25 (27.5) | 3 (5.7) |
 Lower middle | 27 (1.7) | 15 (2.0) | 9 (1.3) | 2 (2.2) | 1 (1.9) |
 Low | 7 (0.4) | 2 (0.3) | 5 (0.7) | 0 (0.0) | 0 (0.0) |
Journal type, n (%) | |||||
 General medical | 73 (4.6) | 28 (3.7) | 43 (6.1) | 1 (1.1) | 1 (1.9) |
 Specialty medical | 1137 (71.2) | 535 (71.0) | 503 (71.8) | 67 (73.6) | 32 (60.4) |
 General pediatric | 110 (6.9) | 63 (8.4) | 35 (5.0) | 8 (8.8) | 4 (7.5) |
 Specialty pediatric | 173 (10.8) | 87 (11.6) | 68 (9.7) | 6 (6.6) | 12 (22.6) |
 Otherb | 105 (6.6) | 40 (5.3) | 52 (7.4) | 9 (9.9) | 4 (7.5) |
Sources of fundingc, n (%) | |||||
 Academic | 228 (14.3) | 96 (12.7) | 118 (16.8) | 9 (9.9) | 5 (9.4) |
 Government | 557 (34.9) | 239 (31.7) | 265 (37.7) | 37 (40.7) | 16 (30.2) |
 Industry | 53 (3.3) | 23 (3.1) | 22 (3.1) | 5 (5.5) | 3 (5.7) |
 Private (foundation) | 193 (12.1) | 81 (10.8) | 97 (13.8) | 8 (8.8) | 7 (13.2) |
 Other | 32 (2.0) | 13 (1.7) | 14 (2.0) | 3 (3.3) | 2 (3.8) |
 No funding | 248 (15.5) | 130 (17.3) | 100 (14.2) | 11 (12.1) | 7 (13.2) |
 Not reported | 543 (34.0) | 281 (37.3) | 215 (30.7) | 29 (31.9) | 18 (34.0) |
Review is an update, n (%) | 32 (2.0) | 18 (2.4) | 11 (1.6) | 2 (2.2) | 1 (1.9) |
Existing a-priori protocol for the reviewd, n (%) | |||||
 Yes (reported) | 246 (15.4) | 130 (17.3) | 90 (12.8) | 16 (17.6) | 10 (18.9) |
 No (reported) | 16 (1.0) | 7 (0.9) | 8 (1.1) | 1 (1.1) | 0 (0.0) |
 Not mentioned | 1336 (83.6) | 616 (81.8) | 603 (86.0) | 74 (81.3) | 43 (81.1) |
Registration of the reviewd, n (%) | |||||
 Yes (reported) | 111 (6.9) | 59 (7.8) | 35 (5.0) | 9 (9.9) | 8 (15.1) |
 No (reported) | 24 (1.5) | 9 (1.2) | 12 (1.7) | 3 (3.3) | 0 (0.0) |
 Not mentioned | 1463 (91.6) | 685 (91.0) | 654 (93.3) | 79 (86.8) | 45 (84.9) |